Plexus Corp (PLXS) Stock Price Quote, News & Filings

Summary

Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.

Website

www.plexus.com

Location

Neenah, WI, US

Phone920 969 6000

Employees20,000

CEOTodd Kelsey

Sector

Information Technology

Industry

Electronic Equipment, Instruments & Components

IPO DateFeb 5, 1986

Ask AI

Company overview

Business model, segments, and competition.

Peer comparison

Metrics vs closest competitors.

Guidance & outlook

Forward guidance and assumptions.

Bull vs bear case

Upside drivers and key risks.

Valuation snapshot

Multiples vs history and peers.

Competitive moat

Defensibility and market position.

Management track record

Leadership and capital allocation history.

How it makes money

A short diagram of the business model.

Latest Documents

Mentions in Filings

… en recorded because management, after consultation with legal counsel, concluded that a loss was not probable. The Company is unable to reasonably estimate the possible loss or range of loss, if any. In December 2025, Plexus Corp., a former contract manufacturer of the Company’s predecessor, BioSig Technologies, Inc., filed a complaint against the Company in the United States District Court for the Eastern District of Wisconsin seeking approxima …
Streamex Corp.Plexus Corp·10-Q - Quarterly report Q3·Q3 26·12 Nov
The Company entered into a new supply agreement with Plexus Corp. for the manufacturing of its second generation device beginning on April 1, 2027. The Company has non-cancellable purchase orders of approximately $4.9 million with this supplier, as of September 30, 2026. This supplier holds $1.6 million of deposits to partially secure materials on the Company’s behalf recorded in other current assets and prepaid expenses. ***Contingencies*** Fr …
Beyond Air, Inc.Plexus Corp·10-Q - Quarterly report Q2·Q2 27·12 Nov
… might result to the Company, may differ materially from our current estimates. 5 --- Table of Contents As described in Supply Chain Strategy above, we entered into a non-exclusive contract manufacturing agreement with Plexus, which is expected to enhance manufacturing scalability and operational efficiency. Volume production has fully transferred to Plexus, with remaining transition and optimization expected to continue into the first quarter …
Evolv Technologies Holdings, Inc.Plexus Corp·10-Q - Quarterly report Q3·Q3 26·10 Nov
… to enable and improve functional activities of daily living (“ADLs”), in the home and community. It is custom constructed by a trained professional during a custom fabrication process for each individual user to meet their specific needs. Our products are designed to help regain function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders.
MYOMO, INC.Plexus Corp·10-Q - Quarterly report Q3·Q3 26·9 Nov
… elops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the ar …
MYOMO, INC.Plexus Corp·EX-99.1 - 8-K - Results of Operations and Financial Condition·Q4 26·9 Nov
… committee financial expert” under SEC guidelines. E-39 --- **Karen M. Rapp** Director since 2024 Age: 59 Board Committees: Audit Committee Other current public-company boards: Microchip Technology Incorporated; Plexus Corp. Business experience and other directorships Ms. Rapp served as chief financial officer of National Instruments Corporation from 2017 through January 2023. Prior to that, she served as Senior Vice President of Corpora …
COHU INCPlexus Corp·DEF 14A - Definitive proxy statement·Q4 26·9 Nov

Key Stats

Trading

Px/Chg 1D$273.13 / +1.06%

Prev Close$242.07

% of 52Wk H78.95%

Avg Volume334.61K

Beta1.15

Mkt Cap7.31B

FD Mkt Cap6.49B

Float

Shrs Out/Float26.76M / 26.38M

Short Float0.03%

Days to Cover2.30

Stock Repurchased$21.04M

Current Valuation

EV7.26B

EV/EBITDA24.46

EV/Sales1.69

P/B4.91

P/S1.70

FCF Yield0.22%

ROE3.34%

ROA1.48%

Current Ratio1.54

Estimates

P/E38.97

Est P/E0.00

Est EPS1.87

Est PEG0.00

Valuation

Metric	5Yr Avg	Feb '23	Feb '24	Jan '25	Feb '26	Oct '26
PRICE-BASED RATIOS
Price / Earnings	72.01	56.20	19.32	35.12	102.67	146.72
Price / Sales	3.08	2.52	0.64	0.99	4.99	6.28
Price / Book Value	3.26	2.59	2.21	2.96	3.63	4.91
Price / Free Cash Flow	79.78	-167.03	43.51	11.50	54.33	456.58
ENTERPRISE VALUE METRICS
Enterprise Value	4,446.4	3,056.0	2,901.2	3,861.3	5,148.8	7,264.8
Enterprise Value / Sales	3.10	2.72	0.69	0.97	4.86	6.24
Enterprise Value / EBITDA	45.75	39.01	11.06	16.34	72.15	90.18
Enterprise Value / EBIT	61.15	48.91	15.07	24.38	98.87	118.51

Financials

Full Financials

Millions USD	5Yr CAGR (%)	Oct '21	Oct '22	Sep '23	Sep '24	Sep '25
INCOME STATEMENT
Revenue	4.6%	3,368.9	3,811.4	4,210.3	3,960.8	4,033.0
Gross Income	5.9%	323.3	347.2	394.6	378.5	406.5
EBITDA	4.2%	235.7	236.9	262.3	236.3	277.4
EBIT	3.4%	174.7	174.2	192.6	158.4	199.6
Net Income	5.6%	138.9	138.2	139.1	111.8	172.9
EPS (Diluted)	7.1%	4.76	4.86	4.95	4.01	6.26
BALANCE SHEET
Cash & ST Inv	3.2%	270.2	274.8	256.2	345.1	306.8
Total Assets	6.2%	2,461.9	3,393.2	3,321.2	3,153.8	3,137.1
Total Liabilities	4.1%	1,433.7	2,297.5	2,106.8	1,829.0	1,682.5
Total Shareholder Equity	9.1%	1,028.2	1,095.7	1,214.4	1,324.8	1,454.6
CASH FLOW
Net Operating Cash Flow	15%	142.6	-26.2	165.8	436.5	249.2
Cap Ex	13.7%	-57.1	-101.6	-104.0	-95.2	-95.3
Free Cash Flow	15.8%	85.5	-127.9	61.8	341.3	154.0

Enterprise Value Bridge

Millions USD		13 Nov '26
Price (As of 13 Nov '26)		208.90
Basic Shares		26.76
Market Cap		5,589.4
Diluted Shares		27.35
Fully Diluted Shares Outstanding		27.35
Fully Diluted Market Cap		5,712.8
+Consolidated Debt		299.3
−In-the-Money Convertible Debt		—
+Capital Leases		23.9
+Operating Leases		—
−Cash & Equivalents		-314.1
−Short-term Investments		-
+Total Preferred		-
−In-the-Money Convertible Preferred		—
−Investments in Unconsolidated Subs		—
+Non-Controlling Interest		-
+Pension Liabilities		—
Enterprise Value		5,574.7

Segment data

Revenue

by Products and services

Asia Pacific Segment59%
Americas Segment30%
Emea Segment11%